Kays Financial Advisory’s Quest Diagnostics DGX Stock Holding History
Bought
Maintained
Sold
Other funds holding DGX
AAMU
FMI
DSA
Kays Financial Advisory's DGX Position: Q2 2019 in Review
Kays Financial Advisory sold out of Quest Diagnostics (DGX) in Q2 2019, closing a stake of 14,920 shares — an estimated $1.34M sold.
Kays Financial Advisory first reported a position in DGX in Q2 2014 and held it in 20 quarters. The position peaked at $3.02M in Q2 2018. 654 funds tracked by Wall St. Rank hold DGX as of Q2 2019.
- Kays Financial Advisory reported no remaining Quest Diagnostics position as of Q2 2019 after selling out during the quarter.
- Kays Financial Advisory sold 14,920 Quest Diagnostics shares in Q2 2019, an estimated $1.34M.
- Kays Financial Advisory first reported a position in Quest Diagnostics in Q2 2014 and held it in 20 quarters.
- Kays Financial Advisory's Quest Diagnostics position peaked at $3.02M in Q2 2018.
- 654 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2019.
Based on Kays Financial Advisory's 13F filing for Q2 2019, filed 24 Jul 2019.